Dysfunctional dendritic cells limit antigen-specific T cell response in glioma
Neuro-Oncology · 14.02.2023 · 25 (2) · 263-276
DOI: 10.1093/neuonc/noac138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 24.05.2022. Verfasst von Mirco Friedrich und 14 weiteren Autor:innen. Beteiligte Einrichtung: DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Hauptthemen laut MEDLINE: Glioblastoma, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Organ Function, Federal Ministry of Education and Research, Heidelberg University.
Abstract (Originalsprache)
Background
Dendritic cells (DC), the most potent professional antigen presenting cells capable of effective cross-presentation, have been demonstrated to license T helper cells to induce antitumor immunity in solid tumors. Specific DC subtypes are recruited to the injured brain by microglial chemokines, locally adapting to distinct transcriptional profiles. In isocitrate dehydrogenase (IDH) type 1 mutant gliomas, monocyte-derived macrophages have recently been shown to display an attenuated intratumoral antigen presentation capacity as consequence of the local accumulation of the oncometabolite R-2-hydroxyglutarate. The functionality and the contribution of DC to the IDH-mutant tumor microenvironment (TME) remains unclear.
Methods
Frequencies and intratumoral phenotypes of human DC in IDH-wildtype (IDHwt) and -mutant high-grade gliomas are comparatively assessed by transcriptomic and proteomic profiling. DC functionality is investigated in experimental murine glioblastomas expressing the model antigen ovalbumin. Single-cell sequencing-based pseudotime analyses and spectral flow cytometric analyses are used to profile DC states longitudinally.
Results
DC are present in primary and recurrent high-grade gliomas and interact with other immune cell types within the TME. In murine glioblastomas, we find an IDH-status-associated major histocompatibility class I-restricted cross-presentation of tumor antigens by DC specifically in the tumor but not in meninges or secondary lymphoid organs of tumor-bearing animals. In single-cell sequencing-based pseudotime and longitudinal spectral flow cytometric analyses, we demonstrate an IDH-status-dependent differential, exclusively microenvironmental education of DC.
Conclusions
Glioma-associated DCs are relevantly abundant in human IDHwt and mutant tumors. Glioma IDH mutations result in specifically educated, dysfunctional DCs via paracrine reprogramming of infiltrating monocytes, providing the basis for combinatorial immunotherapy concepts against IDH mutant gliomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital , Heidelberg, Germany.
- Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
- Department of Neurology, MCTN, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
- Department of Neuropathology, Freiburg University Hospital, Freiburg, Germany.
- Dendritic Cells in Infection and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
ORCID-Profile: Stefan Pusch, Wolfgang Wick, Marco Prinz, Lukas Bunse
Förderung
- Organ Function
- Federal Ministry of Education and Research
- Heidelberg University
- Heidelberg Biosciences International Graduate School
- Konrad-Adenauer Foundation
- German Academic Exchange Service
- German Academic Scholarship Foundation
- German Council of Science and Humanities
Zitieren
APA
Friedrich, M., Hahn, M., Michel, J., Sankowski, R., Kilian, M., Kehl, N., Günter, M., Bunse, T., Pusch, S., von Deimling, A., Wick, W., Autenrieth, S. E., Prinz, M., Platten, M., & Bunse, L. (2023). Dysfunctional dendritic cells limit antigen-specific T cell response in glioma. Neuro-Oncology, 25(2), 263-276. https://doi.org/10.1093/neuonc/noac138
Vancouver
Friedrich M, Hahn M, Michel J, Sankowski R, Kilian M, Kehl N, et al. Dysfunctional dendritic cells limit antigen-specific T cell response in glioma. Neuro-Oncology. 2023;25(2):263-276. doi:10.1093/neuonc/noac138
BibTeX
@article{Friedrich2023,
author = {Friedrich, Mirco and Hahn, Markus and Michel, Julius and Sankowski, Roman and Kilian, Michael and Kehl, Niklas and Günter, Manina and Bunse, Theresa and Pusch, Stefan and von Deimling, Andreas and Wick, Wolfgang and Autenrieth, Stella E and Prinz, Marco and Platten, Michael and Bunse, Lukas},
title = {Dysfunctional dendritic cells limit antigen-specific T cell response in glioma},
journal = {Neuro-Oncology},
year = {2023},
volume = {25},
number = {2},
pages = {263--276},
doi = {10.1093/neuonc/noac138}
}
EUVIMED